The Link Between Tall Stature, Larger Waist Circumference, and Aggressive Prostate Cancer

Excess weight and tall stature were thought to increase prostate cancer risk, but clear evidence of this relationship was lacking. A European Prospective Investigation into Cancer and Nutrition (EPIC) study examined prostate cancer incidence, height, adiposity, and mortality in 141.896 men. During 13.9 years of follow-up, prostate cancer developed in 7.024 participants.
Prostate canceris the most common cancer among men in Europe and the second most common worldwide after lung cancer. Although relatively little is known about its causes, or etiology, studies suggest a hormonal influence. For example, higher circulating levels of insulin-like growth factor I (IGF-I) are associated with prostate cancer risk. Larger body size, including obesity and tall stature, is also thought to affect metabolic and hormonal mechanisms that may promote prostate cancer development. With increasing overweight and obesity worldwide , obesity-related diseases have become a major public health concern.
The study focused on different prostate cancer subtypes. Researchers assessed cancer stage and tumor grade separately. A tumor spreading outside the prostate was classified as advanced-stage, while one confined to the prostate was considered localized. Prostate cancer grade was determined using the Gleason score: scores of 7 or below were classified as low or intermediate grade, and scores of 8 or above as high grade. The Gleason score describes how tumor cells look under the microscope. This was the first study to examine prostate cancer risk factors separately for advanced-stage and high-grade tumors.
You May Also Be Interested In:
According to the Study Findings; in waist circumference measurements, each 10 cm increase raised the risk of death from prostate cancer by 18%. Increasing body mass index also increased the risk of aggressive, rapidly growing and spreading prostate cancer. Height did not affect overall prostate cancer risk, but each 10 cm increase was associated with a 21% increase in aggressive prostate cancer risk and a 17% increase in prostate cancer mortality.
The study showed that taller men and men with greater adiposity have higher risks of developing aggressive prostate cancer and dying from it. Although height cannot be changed, weight control can help reduce prostate cancer risk.
Sources
Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study
BMC Medicine, 13 July 2017
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.